Aria CV is developing a medical device designed to improve the lives of patients living with the disease of pulmonary hypertension.
Aria CV was founded in 2010 by Drs. John Scandurra and Karl Vollmers, formerly Fellows at the University of Minnesota’s Medical Devices Center. Aria has an exclusive license to certain patents from the University of Minnesota. Aria CV’s device has the potential to improve outcomes by reducing the workload on the right side of the heart.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 25, 2020 | Series B | $31M | 1 | — | — | Detail |
Jul 24, 2015 | Series A | $7.80M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Cedar Point Capital | — | Series B |